Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination

Chemo-immunotherapy of breast cancer using vesiculated alpha-tocopheryl succinate in combination with dendritic cell vaccination

Immunotherapy and cancer vaccines in the management of breast cancer

Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice

Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses

Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer

Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study

The immune response to breast cancer, and the case for DC immunotherapy

Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells